表紙
市場調查報告書

造血幹細胞移植(HSCT)的全球市場:2020年∼2024年

Global Hematopoietic Stem Cells Transplantation (Hsct) Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 560883
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
造血幹細胞移植(HSCT)的全球市場:2020年∼2024年 Global Hematopoietic Stem Cells Transplantation (Hsct) Market 2020-2024
出版日期: 2020年03月22日內容資訊: 英文 120 Pages
簡介

全球造血幹細胞移植(HSCT)市場在2020年∼2025年的預測期間內,預計將以6%的年複合成長率增長,達到46億4,000萬美元的規模。技術性進步的設備可得性是市場主要的成長要素。此外個體化醫療的需求不斷提升,預計將更進一步促進市場的成長。

本報告提供全球造血幹細胞移植(HSCT)市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年到2024年的預測

波特的五力分析

各類型市場區隔

  • 市場區隔
  • 各類型比較:市場規模與預測2019-2024
  • 自體HSCT
  • 同類HSCT
  • 各類型的市場機會

客戶形勢

  • 概要

各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模與預測2019-2024
  • 歐洲
  • 北美
  • 亞洲
  • 其他地區
  • 主要國家
  • 各地區的市場機會

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素-需求主導型成長
  • 交易量的成長要素-供給主導型成長
  • 交易量的成長要素-外部要素
  • 交易量的成長要素-需求轉移到鄰近市場
  • 價格上升要素-通貨膨脹
  • 價格成長要素-從低價格單位轉變到高價格單位
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 形勢的創新

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • AllCells Corp.
  • bluebird bio Inc.
  • FUJIFILM HOLDINGS CORPORATION
  • Lineage Cell Therapeutics Inc.
  • Lonza Group Ltd.
  • MEDIPOST Co. Ltd.
  • Merck & Co., Inc.
  • Sanofi
  • 武田藥品工業
  • ThermoGenesis Holdings Inc.

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR41656

Technavio has been monitoring the global hematopoietic stem cells transplantation (HSCT) market and it is poised to grow by USD 4.64 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. Our reports on global hematopoietic stem cells transplantation (HSCT) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by availability of technologically advanced equipment. In addition, growing demand for personalized medicine is anticipated to boost the growth of the global hematopoietic stem cells transplantation (HSCT) market as well.

Market Segmentation

Technavio's ‘ global hematopoietic stem cells transplantation (HSCT) market ’ is segmented as below:

Type:

  • Autologous HSCT
  • Allogeneic HSCT

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global hematopoietic stem cells transplantation (HSCT) market growth

This study identifies growing demand for personalized medicine as the prime reasons driving the global hematopoietic stem cells transplantation (HSCT) market growth during the next few years.

Prominent vendors in global hematopoietic stem cells transplantation (HSCT) market

We provide a detailed analysis of around 25 vendors operating in the global hematopoietic stem cells transplantation (HSCT) market 2020-2024, including some of the vendors such as AllCells Corp., bluebird bio Inc., FUJIFILM Holdings Corp., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck & Co. Inc., Sanofi, Takeda Pharmaceutical Co. Ltd. and ThermoGenesis Holdings Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Autologous HSCT - Market size and forecast 2019-2024
  • Allogeneic HSCT - Market size and forecast 2019-2024
  • Market opportunity by Type

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AllCells Corp.
  • bluebird bio Inc.
  • FUJIFILM Holdings Corp.
  • Lineage Cell Therapeutics Inc.
  • Lonza Group Ltd.
  • MEDIPOST Co. Ltd.
  • Merck & Co., Inc.
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd.
  • ThermoGenesis Holdings Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Market in focus
  • 10.Parent market
  • 13.Market characteristics
  • 15.Offerings of vendors included in the market definition
  • 17.Market segments
  • 22.Global - Market size and forecast 2019 - 2024 ($ billion)
  • 23.Global market: Year-over-year growth 2019 - 2024 (%)
  • 24.Five forces analysis 2019 & 2024
  • 26.Bargaining power of buyers
  • 27.Bargaining power of suppliers
  • 28.Threat of new entrants
  • 29.Threat of substitutes
  • 30.Threat of rivalry
  • 32.Market condition - Five forces 2019
  • 34.Type placement - Market share 2019-2024 (%)
  • 35.Comparison by Type
  • 38.Autologous HSCT - Market size and forecast 2019-2024 ($ billion)
  • 39.Autologous HSCT - Year-over-year growth 2019-2024 (%)
  • 42.Allogeneic HSCT - Market size and forecast 2019-2024 ($ billion)
  • 43.Allogeneic HSCT - Year-over-year growth 2019-2024 (%)
  • 44. Market opportunity by Type
  • 45.Customer landscape
  • 47.Market share by geography 2019-2024 (%)
  • 48.Geographic comparison
  • 51.Europe - Market size and forecast 2019-2024 ($ billion)
  • 53.Europe - Year-over-year growth 2019-2024 (%)
  • 56.North America - Market size and forecast 2019-2024 ($ billion)
  • 58.North America - Year-over-year growth 2019-2024 (%)
  • 61.Asia - Market size and forecast 2019-2024 ($ billion)
  • 63.Asia - Year-over-year growth 2019-2024 (%)
  • 66.ROW - Market size and forecast 2019-2024 ($ billion)
  • 68.ROW - Year-over-year growth 2019-2024 (%)
  • 70.Key leading countries
  • 72.Market opportunity by geography ($ billion)
  • 73.Impact of drivers and challenges
  • 74.Vendor landscape
  • 76.Landscape disruption
  • 78.Industry risks
  • 80.Vendors covered
  • 82.Market positioning of vendors
  • 84.AllCells Corp. - Overview
  • 85.AllCells Corp. - Product and service
  • 86.AllCells Corp. - Key offerings
  • 87.AllCells Corp. - Key customers
  • 88.AllCells Corp. - Segment focus
  • 90.bluebird bio Inc. - Overview
  • 91.bluebird bio Inc. - Business segments
  • 92.bluebird bio Inc. - Key offerings
  • 93.bluebird bio Inc. - Key customers
  • 94.bluebird bio Inc. - Segment focus
  • 96.FUJIFILM Holdings Corp. - Overview
  • 97.FUJIFILM Holdings Corp. - Business segments
  • 98.FUJIFILM Holdings Corp. - Key offerings
  • 99.FUJIFILM Holdings Corp. - Key customers
  • 100.FUJIFILM Holdings Corp. - Segment focus
  • 102.Lineage Cell Therapeutics Inc. - Overview
  • 103.Lineage Cell Therapeutics Inc. - Product and service
  • 104.Lineage Cell Therapeutics Inc. - Key offerings
  • 105.Lineage Cell Therapeutics Inc. - Key customers
  • 106.Lineage Cell Therapeutics Inc. - Segment focus
  • 108.Lonza Group Ltd. - Overview
  • 109.Lonza Group Ltd. - Business segments
  • 110.Lonza Group Ltd. - Key offerings
  • 111.Lonza Group Ltd. - Key customers
  • 112.Lonza Group Ltd. - Segment focus
  • 114.MEDIPOST Co. Ltd. - Overview
  • 115.MEDIPOST Co. Ltd. - Business segments
  • 116.MEDIPOST Co. Ltd. - Key offerings
  • 117.MEDIPOST Co. Ltd. - Key customers
  • 118.MEDIPOST Co. Ltd. - Segment focus
  • 120.Merck & Co. Inc. - Overview
  • 121.Merck & Co. Inc. - Business segments
  • 122.Merck & Co. Inc. - Key offerings
  • 123.Merck & Co. Inc. - Key customers
  • 124.Merck & Co. Inc. - Segment focus
  • 126.Sanofi - Overview
  • 127.Sanofi - Business segments
  • 128.Sanofi - Key offerings
  • 129.Sanofi - Key customers
  • 130.Sanofi - Segment focus
  • 132.Takeda Pharmaceutical Co. Ltd. - Overview
  • 133.Takeda Pharmaceutical Co. Ltd. - Product and service
  • 134.Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 135.Takeda Pharmaceutical Co. Ltd. - Key customers
  • 136.Takeda Pharmaceutical Co. Ltd. - Segment focus
  • 138.ThermoGenesis Holdings Inc. - Overview
  • 139.ThermoGenesis Holdings Inc. - Business segments
  • 140.ThermoGenesis Holdings Inc. - Key offerings
  • 141.ThermoGenesis Holdings Inc. - Key customers
  • 142.ThermoGenesis Holdings Inc. - Segment focus
  • 144.Currency conversion rates for US$
  • 145.Research Methodology
  • 146.Validation techniques employed for market sizing
  • 147.Information sources
  • 149.List of abbreviations